查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968465

治療性低溫療法系統市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

Therapeutic Hypothermia Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球治療性低溫療法系統市場預計將從 2025 年的 3.1145 億美元成長到 2031 年的 4.5727 億美元，複合年成長率達到 6.61%。

這些專用醫療設備旨在透過治療手段降低患者體溫，從而降低血流減少後大腦和重要器官缺血性損傷的風險。推動這一市場發展的主要因素是心臟麻痹和新生兒缺氧缺血性腦病變率的不斷上升，這使得人們迫切需要可靠的體溫管理來提高存活率和改善神經系統預後。美國心臟協會的數據表明，猝死基金會指出，到2025年，美國每年將發生約35萬例院外心臟麻痹，凸顯了有效復甦後照護的必要性。

市場概覽
預測期 2027-2031
市場規模：2025年 3.1145億美元
市場規模：2031年 4.5727億美元
複合年成長率：2026-2031年 6.61%
成長最快的細分市場 冷卻導管
最大的市場 北美洲

儘管先進冷卻系統具有顯著的臨床益處，但其高昂的購置成本以及應對潛在併發症所需的專業培訓，都對市場成長構成了重大障礙。這些財務和營運方面的難題阻礙了這些技術的廣泛應用，尤其是在資源有限的醫療機構和小規模醫院。因此，儘管人們對改善患者預後的需求日益成長，但預算限制和實施的複雜性仍然限制這些技術在某些地區的普及。

市場促進因素

全球心臟麻痹率的不斷上升是治療性低溫系統市場的主要促進因素，凸顯了採用先進的標靶體溫調節（TTM）技術來減輕神經損傷的迫切需求。心臟麻痹後，患者在自主循環恢復期間常面臨再灌注損傷的風險，而透過降低腦代謝率的冷卻系統可以有效緩解這種情況。這種臨床需求正推動重症監護室採用血管內和體表冷卻裝置，以改善復甦後的照護。猝死基金會於2025年1月發布的《最新統計》報告揭示了這項需求的規模。報告顯示，2024年美國CARES註冊中心共記錄了137,119例院外心臟麻痹事件，顯示能夠最大限度提高患者存活率的技術擁有巨大的市場潛力。

同時，隨著新生兒腦病變和新生兒窒息發生率的上升，在新生兒加護病房廣泛應用專業降溫設備已成為迫切需求。低溫療法已成為缺氧缺血性腦病變（HIE）新生兒的標準治療方法，因為它能顯著降低永久性認知和運動障礙的發生率。根據Hope for HIE於2025年6月發布的《新生兒HIE現狀》報告，全球每年約有120萬個嬰兒患有此病，保證了精準新生兒降溫解決方案的持續需求。這種臨床需求正在推動製造商的商業性成長；例如，BrainCool AB公司在2025年2月報告稱，其在2024年第四季出貨了39套系統，創下了1,200萬瑞典克朗（SEK）的季度銷售額紀錄。這證實了這些關鍵系統在重症監護環境中的快速普及。

市場挑戰

先進冷卻系統的高昂購置成本以及對專業培訓的需求，是全球治療性低溫療法系統市場成長的主要障礙。這些財務和營運方面的要求限制了這些設備融入標準治療通訊協定的能力，尤其是在發展中地區和預算有限的醫療機構。當醫院優先考慮支出時，溫度管理系統所需的大量初始投資往往會導致實施延遲，因為功能更全面或更迫切需要的設備會優先考慮。這種對採用這些系統的猶豫直接影響了市場滲透率和整體成長。

此外，嚴峻的經濟環境是醫療機構面臨的一大難題，也進一步加劇了對資本密集投資的猶豫。根據美國醫院協會 (AHA) 發布的《2025 年報告》，94% 的醫療機構管理者預計將推遲設備升級，以應對持續的財務壓力。這項數據凸顯了醫院面臨的嚴峻財務困境，不斷上漲的營運成本和有限的資本儲備迫使醫院採取保守的籌資策略。因此，儘管人們對治療性低溫療法的臨床益處已有充分的了解，但設備的高昂成本和所需培訓計畫的資源負擔有效地限制了該療法的廣泛應用。

市場趨勢

市場正明顯轉向非侵入性表面冷卻方法，以降低與侵入性血管內導管插入術相關的操作風險。先進的表面冷卻系統使醫務人員能夠立即開始體溫管理，避免了建立中心靜脈通路所帶來的延誤和感染風險。這種對外部方式的偏好在領先製造商的財務表現中得到了清晰的體現。例如，Gentherm公司在其2025年2月發布的2024年第四季及全年財報中指出，其醫療保健業務收入在2024年達到4,980萬美元，年增8.1%。這主要歸功於市場對錶面溫度控管解決方案的強勁需求。這一成長表明，在救命急救環境，非侵入性技術正持續發展。

同時，攜帶式院前降溫系統的出現正在革新中風和心臟麻痹的早期療育策略。電池供電的經鼻降溫技術使急救人員能夠在患者到達醫院前實施神經保護性降溫，從而延長關鍵治療窗口期。持續進行的攜帶式現場選擇性腦部降溫設備的臨床研究進一步推動了這一趨勢。值得注意的是，BrainCool AB公司在2024年7月的新聞稿中宣布，首例患者已入組重要的COTTIS 2試驗，該試驗旨在評估RhinoChill攜帶式經鼻降溫系統在血栓切除術中的應用。這標誌著在彌合急救轉運和重症監護之間的差距方面邁出了重要一步。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球治療性低溫系統市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（冷卻導管、水毯、冷卻帽、其他）
    • 按應用領域（神經病學、心臟病學、新生兒護理等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美治療性低溫系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲治療性低溫療法系統市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區治療性低溫系統的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲治療性低溫療法系統的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲治療性低溫系統的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球治療性低溫療法系統市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Belmont Medical Technologies
  • BrainCool AB
  • ZOLL Medical Corporation
  • Becton, Dickinson, and Company
  • Stryker Corporation
  • EM-MED Sp. z oo
  • Life Recovery Systems
  • Dragerwerk AG & Co. KGaA
  • Terumo Cardiovascular Systems Corporation
  • pfm medical gmbh

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23743

The Global Therapeutic Hypothermia Systems Market is projected to expand from USD 311.45 Million in 2025 to USD 457.27 Million by 2031, achieving a compound annual growth rate of 6.61%. These specialized medical devices are designed to lower a patient's body temperature to a therapeutic level, mitigating the risk of ischemic injury to the brain and vital organs after periods of reduced blood flow. A major catalyst for this market is the increasing incidence of cardiac arrest and neonatal hypoxic-ischemic encephalopathy, which creates a strong need for dependable temperature management to improve survival rates and neurological outcomes. Highlighting this urgent need, the Sudden Cardiac Arrest Foundation reported in 2025 that American Heart Association data indicates approximately 350,000 out-of-hospital cardiac arrests take place annually in the United States, emphasizing the necessity for effective post-resuscitation care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 311.45 Million
Market Size 2031USD 457.27 Million
CAGR 2026-20316.61%
Fastest Growing SegmentCooling Catheters
Largest MarketNorth America

Despite the clear clinical benefits, market growth faces significant hurdles due to the high purchase price of advanced cooling units and the need for specialized training to handle potential complications. These financial and operational obstacles frequently hinder the broad implementation of these technologies, especially within healthcare facilities that have limited resources or smaller hospital settings. Consequently, while the demand for improved patient outcomes drives interest, budget constraints and the complexity of deployment continue to restrict widespread adoption in certain sectors.

Market Driver

The increasing global frequency of cardiac arrest acts as a major driver for the therapeutic hypothermia systems market, creating a critical need for advanced targeted temperature management (TTM) to limit neurological injury. Upon the return of spontaneous circulation following cardiac arrest, patients are often at risk of reperfusion injury, a condition that cooling systems mitigate by lowering cerebral metabolic rates. This clinical necessity fuels the adoption of both intravascular and surface cooling units within intensive care environments to enhance post-resuscitation treatment. The magnitude of this demand is illustrated by the Sudden Cardiac Arrest Foundation's January 2025 'Latest Statistics' report, which noted that 137,119 out-of-hospital cardiac arrest events were recorded in the United States' CARES registry during 2024, demonstrating a significant addressable market for technologies capable of maximizing patient survival.

Concurrently, the rising prevalence of neonatal encephalopathy and birth asphyxia is compelling neonatal intensive care units to widely adopt specialized cooling devices. Therapeutic hypothermia has become the standard treatment for newborns with hypoxic-ischemic encephalopathy (HIE) because it substantially lowers the likelihood of permanent cognitive and motor impairments. According to the 'State of Neonatal HIE' review by Hope for HIE in June 2025, approximately 1.2 million infants worldwide develop this condition annually, ensuring a steady demand for precise neonatal cooling solutions. This clinical requirement is driving commercial growth for manufacturers; for example, BrainCool AB reported in February 2025 that it delivered 39 systems in the fourth quarter of 2024, achieving record quarterly sales of SEK 12.0 million, which underscores the rapid uptake of these essential systems in critical care settings.

Market Challenge

The substantial acquisition costs associated with advanced cooling units, along with the requirement for specialized personnel training, represent a significant obstacle to the growth of the Global Therapeutic Hypothermia Systems Market. These financial and operational demands restrict the capacity of healthcare institutions, especially those in developing regions or with limited budgets, to incorporate these devices into standard care protocols. When hospitals must prioritize their spending, the heavy upfront investment required for temperature management systems frequently results in postponement in favor of equipment that is more versatile or immediately essential. This reluctance creates a direct link to slower market penetration and dampened overall growth rates.

Moreover, the challenging economic landscape for healthcare providers has further cemented this hesitation regarding capital-intensive investments. A 2025 report from the American Hospital Association indicated that 94% of healthcare administrators anticipated delaying equipment upgrades to cope with persistent financial pressures. This statistic highlights the intense fiscal difficulties hospitals face, where increasing operational expenses and finite capital reserves mandate a conservative procurement strategy. As a result, even though the clinical advantages of therapeutic hypothermia are well understood, the combination of high device pricing and the resource burden of necessary training programs effectively limits widespread implementation.

Market Trends

The market is observing a distinct shift toward non-invasive surface cooling methods to reduce the procedural risks linked to invasive intravascular catheters. Advanced surface systems enable medical staff to begin temperature management immediately, avoiding the delays and infection risks associated with establishing central venous access. This preference for external modalities is evident in the financial results of leading manufacturers in the sector; for instance, Gentherm reported in its February 2025 '2024 Fourth Quarter and Full Year Results' that its Medical segment revenue rose to $49.8 million in 2024, an 8.1% increase year-over-year, largely due to strong demand for surface thermal management solutions. This growth indicates a sustained pivot toward non-invasive technologies for critical care environments.

At the same time, the emergence of portable pre-hospital cooling systems is revolutionizing early intervention strategies for stroke and cardiac arrest. By employing battery-operated or intranasal technologies, emergency responders can induce neuroprotective cooling before a patient reaches the hospital, thereby extending the critical therapeutic window. This trend is bolstered by ongoing clinical research into mobile devices designed for selective brain cooling in the field. Notably, BrainCool AB announced in a July 2024 press release that the first patient had been enrolled in the pivotal COTTIS 2 study to assess the RhinoChill portable intranasal cooling system during thrombectomy procedures, marking a significant step in bridging the gap between ambulance transport and intensive care.

Key Market Players

  • Belmont Medical Technologies
  • BrainCool AB
  • ZOLL Medical Corporation
  • Becton, Dickinson, and Company
  • Stryker Corporation
  • EM-MED Sp. z o.o.
  • Life Recovery Systems
  • Dragerwerk AG & Co. KGaA
  • Terumo Cardiovascular Systems Corporation
  • pfm medical gmbh

Report Scope

In this report, the Global Therapeutic Hypothermia Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Therapeutic Hypothermia Systems Market, By Product

  • Cooling Catheters
  • Water Blankets
  • Cool Caps
  • Others

Therapeutic Hypothermia Systems Market, By Application

  • Neurology
  • Cardiology
  • Neonatal Care
  • Others

Therapeutic Hypothermia Systems Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Hypothermia Systems Market.

Available Customizations:

Global Therapeutic Hypothermia Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Therapeutic Hypothermia Systems Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cooling Catheters, Water Blankets, Cool Caps, Others)
    • 5.2.2. By Application (Neurology, Cardiology, Neonatal Care, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Therapeutic Hypothermia Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Therapeutic Hypothermia Systems Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Therapeutic Hypothermia Systems Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Therapeutic Hypothermia Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Therapeutic Hypothermia Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Therapeutic Hypothermia Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Therapeutic Hypothermia Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Therapeutic Hypothermia Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Therapeutic Hypothermia Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Therapeutic Hypothermia Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Therapeutic Hypothermia Systems Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Therapeutic Hypothermia Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Therapeutic Hypothermia Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Therapeutic Hypothermia Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Therapeutic Hypothermia Systems Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Therapeutic Hypothermia Systems Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Therapeutic Hypothermia Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Therapeutic Hypothermia Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Therapeutic Hypothermia Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Therapeutic Hypothermia Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Therapeutic Hypothermia Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Therapeutic Hypothermia Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Therapeutic Hypothermia Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Therapeutic Hypothermia Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Therapeutic Hypothermia Systems Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Belmont Medical Technologies
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BrainCool AB
  • 15.3. ZOLL Medical Corporation
  • 15.4. Becton, Dickinson, and Company
  • 15.5. Stryker Corporation
  • 15.6. EM-MED Sp. z o.o.
  • 15.7. Life Recovery Systems
  • 15.8. Dragerwerk AG & Co. KGaA
  • 15.9. Terumo Cardiovascular Systems Corporation
  • 15.10. pfm medical gmbh

16. Strategic Recommendations

17. About Us & Disclaimer